TY - JOUR T1 - Oral immunotherapy: The answer to peanut allergy? JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 104 LP - 109 DO - 10.3949/ccjm.88a.20130 VL - 88 IS - 2 AU - Rachel M. Whitsel AU - Jaclyn A. Bjelac AU - Ahila Subramanian AU - Alice E. W. Hoyt AU - Sandra J. Hong Y1 - 2021/02/01 UR - http://www.ccjm.org/content/88/2/104.abstract N2 - Peanut and tree-nut allergies have increased dramatically in prevalence, especially in children. Historically, children with food allergies have been treated through strict avoidance of the allergen. Recently, an oral preparation of peanut allergen (Palforzia) was approved for immunotherapy (ie, desensitization) in children 4 to 17 years old. This article reviews oral immunotherapy and its role in children with peanut allergies. ER -